Table 3.

Regression model analysis for diagnosis testing.

Stages	Variable	Univariate analysis			Multiivariate analysis
		B	OR (95%CI)	P-value	B	OR (95%CI)	P-value
All CRC	CXCL7	2.763	15.850 (9.957–25.231)	<0.001	2.156	8.637 (5.198–14.352)	<0.001
	CEA	0.480	1.616 (1.420–1.840)	<0.001	0.314	1.369 (1.192–1.573)	<0.001
	CA125	0.078	1.081 (1.058–1.104)	<0.001	0.062	1.064 (1.032–1.097)	<0.001
	CA19-9	0.072	1.074 (1.053–1.096)	<0.001	0.057	1.059 (1.031–1.087)	<0.001
Stage I–II	CXCL7	2.234	9.333 (5.790–15.044)	<0.001	1.796	6.824 (3.570–10.166)	<0.001
	CEA	0.453	1.572 (1.351–1.831)	<0.001	0.309	1.363 (1.164–1.595)	<0.001
	CA125	0.075	1.077 (1.052–1.103)	<0.001	0.065	1.067 (1.003–1.101)	<0.001
	CA19-9	0.061	1.063 (1.040–1.086)	<0.001	0.054	1.056 (1.026–1.086)	<0.001
Male subgroup	CXCL7	3.875	48.164 (21.716–106.825)	<0.001	3.206	24.676 (10.471–58.151)	<0.001
	CEA	0.542	1.720 (1.438–2.056)	<0.001	0.360	1.433 (1.122–1.830)	0.004
	CA125	0.078	1.081 (1.053–1.111)	<0.001	0.056	1.058 (1.013–1.105)	0.011
	CA19-9	0.066	1.068 (1.043–1.094)	<0.001	0.040	1.041 (1.006–1.077)	0.020
Female subgroup	CXCL7	1.711	5.533 (3.097–9.883)	<0.001	1.158	3.185 (1.614–6.285)	0.001
	CEA	0.405	1.499 (1.256–1.789)	<0.001	0.296	1.345 (1.146–1.578)	<0.001
	CA125	0.076	1.079 (1.042–1.116)	<0.001	0.071	1.075 (1.026–1.12)	0.002
	CA19-9	0.083	1.087 (1.047–1.128)	<0.001	0.084	1.088 (1.036–1.142)	0.001